| | 8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide|乌帕替尼杂质08 基本信息 更多信息 |
| 中文名称: | 乌帕替尼杂质08 | | 中文同义词: | 乌帕替尼杂质08;8-((3R,4S)-4-乙基-1-((2,2,2-三氟乙基)氨基甲酰基)吡咯烷-3-基)-N-(2,2,2,2-三氟乙基)-3H-咪唑并[1,2-A]吡咯并[2,3-E]吡嗪-3-甲酰胺;乌帕替尼杂质G;乌怕替尼杂质08;乌帕替尼杂质23 | | 英文名称: | 8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide | | 英文同义词: | 8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide;Upatinib impurity G;Ubatinib Impurity 08;Dienogest Impurity 30;(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylic acid;A-1666715.0;RMA-866;Urelitide Impurity 12 | | CAS号: | 2715120-86-6 | | 分子式: | C20H21F6N7O2 | | 分子量: | 505.42 | | EINECS号: | | ![8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide|乌帕替尼杂质08](/CAS/20211123/GIF/2715120-86-6.gif) |
|
| 按国家浏览8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide国外供应商 |
中国供应商 |
|
8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|